Sign Out
Each mL of concentrate contains 20 mg panitumumab.
Each vial contains: 100 mg (5 mL vial) of panitumumab (20 mg/mL).
When prepared according to the instructions given in Instructions for Use/Handling under Cautions for Usage, the final panitumumab concentration should not exceed 10 mg/mL.
Panitumumab is a fully human monoclonal IgG2 antibody produced in a mammalian cell line (CHO) by recombinant DNA technology.
Excipient with known effect: Each mL of concentrate contains 0.150 mmol sodium, which is 3.45 mg sodium.
Colourless, pH 5.6 to 6.0 solution that may contain translucent to white, visible amorphous, proteinaceous panitumumab particles.
Excipients/Inactive Ingredients: Sodium chloride, Sodium acetate trihydrate, Glacial acetic acid (for pH-adjustment), Water for injection.
